Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    Interleukin-2 in Metastatic Melanoma quan
Show Display Options
Rank Status Study
1 Terminated Interleukin-2 in Metastatic Melanoma
Condition: Melanoma Metastatic
Intervention: Drug: Interleukin-2
2 Withdrawn Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma
Condition: Metastatic Melanoma
Intervention: Drug: Cyclophosphamide and Interleukin 2
3 Withdrawn Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer
Conditions: Melanoma;   Metastatic Kidney Cancer
Intervention: Drug: Interleukin-2 (IL-2)

Study has passed its completion date and status has not been verified in more than two years.